[Antibody response of patients with severe acute respiratory syndrome (SARS) to nucleocapsid antigen of SARS-associated coronavirus]
- PMID: 12865207
[Antibody response of patients with severe acute respiratory syndrome (SARS) to nucleocapsid antigen of SARS-associated coronavirus]
Abstract
Objective: To assess serum antibody responses of patients with severe acute respiratory syndrome (SARS) to nucleocapsid (N) antigen of SARS-associated coronavirus.
Methods: The serum levels of IgM and IgG antibodies to N antigen were measured in 200 healthy blood donors and 13 SARS patients at different time points of acute and convalescent phases using indirect enzyme-linked immunosorbent assay (ELISA) with N fusion proteins of SARS-associated coronaviruses.
Results: The IgM positive critical value of 0.233 and IgG of 0.239 were selected as the threshold value for positive results that equals the product of 2.1 and the mean IgM and IgG levels of 200 healthy blood donors. In 13 patients with SARS, the antibody responses to N antigen were not detectable in the first week after the onset of symptoms. The IgM and IgG seroprotection rates were 83.3% and 66.7% respectively in the second week, both reaching 100% at the third week. IgM seroprotection rates was 61.5% in the second month, and 38.5% at third month. The IgG peaked one month after the onset and remained at high levels in the following 2 months.
Conclusion: The antibody responses suggest that N protein of SARS is immunodominant and plays an important role in viral pathogenesis. This ELISA-based test for detecting anti- N antigen may be of significant value for SARS diagnosis.
Similar articles
-
Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus.Clin Diagn Lab Immunol. 2004 Jul;11(4):665-8. doi: 10.1128/CDLI.11.4.665-668.2004. Clin Diagn Lab Immunol. 2004. PMID: 15242938 Free PMC article.
-
Detection of specific antibodies to severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2004 May;42(5):2306-9. doi: 10.1128/JCM.42.5.2306-2309.2004. J Clin Microbiol. 2004. PMID: 15131220 Free PMC article.
-
Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia.J Clin Microbiol. 2005 Jul;43(7):3054-8. doi: 10.1128/JCM.43.7.3054-3058.2005. J Clin Microbiol. 2005. PMID: 16000415 Free PMC article.
-
[Diagnostic tests: SARS-Corona virus].Nihon Rinsho. 2005 Jul;63 Suppl 7:343-5. Nihon Rinsho. 2005. PMID: 16111269 Review. Japanese. No abstract available.
-
Laboratory diagnosis of SARS.Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1083-9. doi: 10.1098/rstb.2004.1493. Philos Trans R Soc Lond B Biol Sci. 2004. PMID: 15306394 Free PMC article. Review.
Cited by
-
Development of a Western blot assay for detection of antibodies against coronavirus causing severe acute respiratory syndrome.Clin Diagn Lab Immunol. 2004 Mar;11(2):417-22. doi: 10.1128/cdli.11.2.417-422.2004. Clin Diagn Lab Immunol. 2004. PMID: 15013997 Free PMC article.
-
Coupling multiplex RT-PCR to a gene chip assay for sensitive and semiquantitative detection of severe acute respiratory syndrome-coronavirus.Lab Invest. 2004 Sep;84(9):1085-91. doi: 10.1038/labinvest.3700136. Lab Invest. 2004. PMID: 15195120 Free PMC article.
-
Molecular advances in severe acute respiratory syndrome-associated coronavirus (SARS-CoV).Genomics Proteomics Bioinformatics. 2003 Nov;1(4):247-62. doi: 10.1016/s1672-0229(03)01031-3. Genomics Proteomics Bioinformatics. 2003. PMID: 15629054 Free PMC article. Review.
-
The laboratory diagnosis of severe acute respiratory syndrome: emerging laboratory tests for an emerging pathogen.Clin Biochem Rev. 2004 May;25(2):133-41. Clin Biochem Rev. 2004. PMID: 18458711 Free PMC article.
-
Organ distribution of severe acute respiratory syndrome (SARS) associated coronavirus (SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways.J Pathol. 2004 Jun;203(2):622-30. doi: 10.1002/path.1560. J Pathol. 2004. PMID: 15141376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Miscellaneous